Molgramostim (Molgramostim)
Overview of Molgramostim
Molgramostim is a human growth factor made by recombinant DNA technology with actions and uses similar to Filgrastim. It stimulates the production of white blood cells in bone marrow. Molgramostim is used to increase the white blood cell production in patient whose bone marrow function is depressed by cancer therapy. Molgramostim is also being used in the treatment of AIDS.
Indication of Molgramostim
Molgramostim is primarily indicated in conditions like Acceleration of myeloid recovery following bone marrow transplantation, Adjunct in ganciclovir treatment, AIDS, Aplastic anemia, Bone marrow transplantation, Cytotoxic chemotherapy, Leucopaecia, Leukopenia, Myclodysplastic syndrome, Myelodysplastic syndrome, and can also be given in adjunctive therapy as an alternative drug of choice in Cancer.
Contraindication of Molgramostim
Molgramostim is contraindicated in conditions like Myeloid leukaemia.
Side Effects of Molgramostim
Molgramostim produces potentially life-threatening effects which include Cardiac arrhythmias, Cardiac failure, Anaphylactic reactions. which are responsible for the discontinuation of Molgramostim therapy.,The signs and symptoms that are produced after the acute overdosage of Molgramostim include Convulsions, Cerebrovascular disorders.,The symptomatic adverse reactions produced by Molgramostim are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Nausea, Vomiting, Anorexia, Diarrhea, Dyspnea, Abdominal pain, Chills, Rashes, Confusion, Pruritus, SweatingX, Hypotension, Flushing, Asthenia, StomatitisX, Syncope, Chest pain, Rigors, Confusion, dizziness, Hypotension.
Precautions of Molgramostim
Caution in the patient with pre-existing pulmonary disease or a history of autoimmune disease. Regular monitoring of the white blood, differential blood counts, platelet count, hematocrit and serum albumin level is very important, safty in pregnancy is not established.